Drugs / Volinanserin
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00070694 | Sep 2003 → Oct 2004 | depressive disorder | National Institute of Mental Health (NIMH) | Completed | No outcome recorded |
| Phase 34 trials | ||||||
| Phase 3 | NCT00788515 | Nov 2008 → Jan 2009 | sleep disorder, initiating and maintaining sleep | Sanofi | Terminated | No outcome recorded |
| Phase 3 | NCT00495885 | Jun 2007 → Oct 2008 | sleep disorder, initiating and maintaining sleep | Sanofi | Completed | No outcome recorded |
| Phase 3 | NCT00464061 | Apr 2007 → Mar 2009 | sleep disorder, initiating and maintaining sleep | Sanofi | Terminated | No outcome recorded |
| Phase 3 | NCT00464243 | Apr 2007 → Jan 2008 | sleep disorder, initiating and maintaining sleep | Sanofi | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | volinanserin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00495885 ↗ |
| Known as | M100907 | “Drug: Volinanserin (M100907)” NCT00788515 ↗1“volinanserin (M100907)” NCT00495885 ↗ |
| Known as | MDL100.907 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00070694 ↗ |
| Known as | Volinanserina | ChEMBL registry synonym — accepted as the source's own label CHEMBL74355 ↗ |
| Known as | Volinanserine | ChEMBL registry synonym — accepted as the source's own label CHEMBL74355 ↗ |
| Action | Inhibit | “Serotonin 2a (5-HT2a) receptor antagonist” CHEMBL74355 ↗1“5-HT2A antagonist” NCT00070694 ↗ |
| Modality | Small molecule | — CHEMBL74355 ↗ |
| Route | Oral | “oral administration” NCT00464061 ↗ |
| Target | HTR2A | “Serotonin 2a (5-HT2a) receptor antagonist” CHEMBL74355 ↗ |